We’re developing drug innovations through plant extraction technologies.
According to the World Health Organisation more than 11 million people are diagnosed with cancer each year and with 16 million new cases predicted by 2020, this is a real crisis for health systems worldwide.
Curing a disease which strikes indiscriminately and often without warning is a priority for researchers, scientists, drugs companies and the medical profession as a whole but, until this challenge has been met, the development of more effective treatments for people with the disease is key to the improved prognosis for those who have it.
As governments struggle to find sufficient funds to treat existing and new cancer patients effectively, and provide palliative, supportive and terminal care, what can be done to improve existing treatments and ultimately find a cure?
As we look deeper for treatments and cures evolving techniques, such as the extraction of pharmaceuticals from plants to increase the effectiveness of chemotherapy drugs, is helping ease the strain on worldwide health services.
Companies like Advanced Extraction Technology, based in the Yorkshire & Humber region, are at the forefront of these developments specialising in extracting pharmaceutical compounds from medicinal plants and research into the compounds produced.
Using sub-critical water extraction (SWE) the company can more efficiently extract poorly soluble compounds that are difficult to recover using traditional techniques, producing high potency extracts that are not yet the basis of a UK medicine.
The Yorkshire & Humber region boasts more than 300 healthcare technology companies including multinational organisations like Smith & Nephew, Johnson & Johnson, Reckitt Benkiser and Seven Seas.
The healthcare sector in the region is growing 4 times faster than in any other UK region and employs more than 10,000 people thanks to exceptional access to clinical trials, pioneering research and development and one of Europe’s largest teaching hospitals being based there.
The Yorkshire and Humber region also attracts £347 million in academic research per year and boasts Europe’s largest cancer treatment facility and several internationally renowned research organisations.
Yorkshire and Humber is driving the fight against cancer and other terminal diseases. As the human and financial costs rise the region offers companies the knowledge, support and expertise they need to pursue pioneering treatments and business success.
Our role is to support foreign owned businesses who wish to set up operations in the Yorkshire and Humber region of the UK. For more information on what service and support we can offer click here or to contact us now click here.